Want to see BDRX full AI Analyst Report?

Biodexa Pharmaceuticals (BDRX) Income Statement

557 Followers

Biodexa Pharmaceuticals Income Statement

Last quarter (Q2 2026), Biodexa Pharmaceuticals's total revenue was £0.00, a decrease of ― from the same quarter last year. In Q2, Biodexa Pharmaceuticals's net income was £-1.88M. See Biodexa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	£ 0.00	£ 0.00	£ 381.00K	£ 699.00K	£ 578.00K
Gross Profit	£ -184.86K	£ -5.44M	£ -3.69M	£ -4.41M	£ -4.08M
Operating Expenses	£ 8.08M	£ 3.76M	£ 4.33M	£ 4.52M	£ 2.92M
Depreciation and Amortization	£ 184.86K	£ 117.00K	£ 283.00K	£ 174.00K	£ 403.00K
EBITDA	£ -8.08M	£ -9.08M	£ -7.16M	£ -8.26M	£ -5.66M
Operating Income	£ -8.27M	£ -9.20M	£ -8.01M	£ -8.93M	£ -7.00M
Other Income/Expenses	£ 1.92M	£ 3.22M	£ 529.00K	£ 444.00K	£ 892.00K
Pretax Income	£ -6.35M	£ -5.98M	£ -7.49M	£ -8.49M	£ -6.11M
Net Income	£ -6.24M	£ -5.73M	£ -7.08M	£ -7.66M	£ -5.46M
Per Share Metrics
Basic EPS	£ -400.00	£ -3.71K	£ -69.64K	£ -4.77M	£ -4.66M
Diluted EPS	£ -400.00	£ -3.71K	£ -69.64K	£ -4.77M	£ -4.66M
Weighted Average Shares Outstanding	21.94K	1.98K	126.00	1.00	1.00
Weighted Average Shares Outstanding (Diluted)	21.94K	1.98K	126.00	1.00	1.00

Currency in GBP

Biodexa Pharmaceuticals (BDRX) Income Statement

Biodexa Pharmaceuticals Income Statement

Biodexa Pharmaceuticals Earnings and Revenue History